Background
As a frequent type of human gynecological malignancies worldwide, cervical cancer (CC) is depicted as one of the dominating causes contributing to cancer-associated death in women [
1,
2]. It is estimated that that nearly 500,000 new cases are diagnosed with CC annually [
3]. In China, CC is also regarded as one of the most prevalent lethal tumors. Over the past few years, in spite of the application of human papillomavirus (HPV) vaccine in treatment, CC is still a major stumbling block for female health [
1,
4]. The majority of patients at an early stage of CC are likely to be cured through surgery [
5], whereas no or limited efficient therapeutic approaches for those at the advanced stages [
6]. In order to make advances in the treatment of CC, researchers have focused on exploring and developing tumor-particular biomarkers for CC [
7]. For example, melatonin was identified as a new adjuvant agent in treating patients with CC [
8], so was curcumin [
9]. However, more efforts should be made in developing new effective therapeutic strategies for CC. Hence, it is imperative to make in-depth exploration of the underlying molecular mechanisms in CC.
Non-coding RNAs (ncRNAs) have been commonly considered as the potential key modulators in gene regulation to impact on tumor development [
10,
11], including genetic and epigenetic manners [
12]. In recent years, ncRNAs have been indicated as clinical biomarkers in diverse diseases [
13,
14], including cancer [
15,
16]. As a member of ncRNAs, circular RNAs (circRNAs) own a covalently closed structure which are tolerant to RNase R-mediated degradation [
17,
18]. Increasing analyses have suggested the abnormal expression of circRNAs in various cancers [
19,
20], including CC [
21,
22]. Emerging researches have testified the implication of circRNAs in tumorigenesis and progression via regulation of different biological processes, which includes cell proliferation, migration and invasion [
23‐
25]. Emerged as a new circRNA, circOSBPL10 (circbase ID: hsa_circ_0064669) is derived from back-splicing of OSBPL10 mRNA (messenger RNA). To our knowledge, the critical regulatory mechanism of circOSBPL10 has not been investigated in CC yet.
In this study, the main purpose was to decipher the potential regulatory role of circOSBPL10 in CC. Data from a series of assays uncovered that FOXA1-induced upregulation of circOSBPL10 contributes to CC progression via miR-1179/UBE2Q1 axis, revealing that circOSBPL10 might be a hopeful biomarker for CC.
Methods
Cell culture
Human normal cervical epithelial cells (H8) and human CC cells (C33A, CaSki, HeLa and SiHa) were bought from Chinese Academy of Sciences (Shanghai, China). Cells were cultured with Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA, USA) adding 10% fetal bovine serum (FBS; Invitrogen), 1% penicillin/streptomycin (Sigma-Aldrich, Milan, Italy), and then incubated in an incubator of 5% CO2 at 37 °C.
Cell transfection
HeLa and SiHa cells were transfected with specific short hairpin RNAs (shRNAs) against circOSBPL10 (sh-circOSBPL10#1#2), FOXA1 (sh-FOXA1#1#2) and their corresponding negative control (NC) sh-NC, as well as pcDNA3.1/circOSBPL10, pcDNA3.1/UBE2Q1, pcDNA3.1/FOXA1 and empty pcDNA3.1 (±) circRNA Mini vector, empty pcDNA3.1 vector, severally. The miR-1179 mimics, miR-1179 inhibitor, NC mimics and NC inhibitor were synthesized by GenePharma (Shanghai, China). Transfection experiments were executed by Lipofectamine 2000 (Invitrogen).
Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA of cells was isolated using TRIzol reagent, followed by cDNA (complementary DNA) synthesis with Reverse Transcription Kit (Invitrogen). RT-qPCR was measured by SYBR-Green Real-Time PCR Kit (Takara, Tokyo, Japan) operated on Bio-Rad CFX96 system (Takara). Relative expression level was calculated utilizing 2
−ΔΔCt method with normalization to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6. The sequences of primers were presented in Additional file
1: Table S1.
Cell counting kit-8 (CCK-8)
In short, 1 × 103 cells were plated into a 96-well plate. After incubation for specific times (24, 48, 72, 96 h), cells were processed with 10 μL of CCK-8 reagent for additional 4 h. Absorbance at 450 nm was measured via a microplate reader (Olympus, Tokyo, Japan).
Transfected cells (1 × 103) were first coated into 6-well plates. After 2 weeks of incubation, cells were rinsed with phosphate buffer saline (PBS; Sigma-Aldrich, San Francisco, USA), fixed in methanol (Sigma-Aldrich) and dyed using crystal violet (Sigma-Aldrich). The visible colonies were counted manually.
ActinomycinD (ActD) and RNase R treatment
To block transcription, 2 mg/ml Actinomycin D (ActD; Sigma-Aldrich) or dimethylsulphoxide (DMSO; Sigma-Aldrich) was added into culture medium. Total RNA was cultivated with or without 3 U/μg of RNase R (Epicentre Technologies, Madison, WI, USA) for 30 min. After treatment with ActD or RNase R, RT-qPCR was applied for determining the expression levels of circOSBPL10 and OSBPL10 mRNA.
Nucleic acid electrophoresis
Convergent primers and divergent primers were designed to amplify OSBPL10 mRNA or circOSBPL10. The level of circOSBPL10 in PCR products from cDNA and genomic DNA was examined by agarose gels with TE (Tris-ethylene diamine tetraacetic acid) buffer from Thermo Scientific (Waltham, MA, USA).
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay
Apoptosis transfected SiHa and HeLa cells were assessed utilizing TUNEL Apoptosis Kit (Invitrogen). 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) was employed to dye above cells. The percentage of positive stained cells was observed by fluorescence microscopy (Olympus) and then analyzed.
Flow cytometry analysis
Cell apoptosis analysis was performed via Cell Apoptosis Analysis Kit (Takara). After incubation in 6-well plates, SiHa and HeLa cells were rinsed with PBS and resuspended in binding buffer. Followed by fixation with 70% ice-cold ethanol (Sigma-Aldrich), cells were double-stained by Annexin V-fluorescein isothiocyanate and propidium iodide. Last, cell apoptosis rate was detected by Flow Cytometer (Becton–Dickinson, MA, USA).
Migration assay
Cell migration abilities were examined using transwell chambers (Corning, NY, USA). Transfected cells with serum-free medium were placed into top compartment, while medium with 10% FBS was added into the lower compartment. 48 h later, cells in the lower chamber were immobilized and dyed in methanol and crystal violet, separately. Then migratory cells were then counted in five random chosen fields under a microscope (Olympus).
Wound healing
SiHa and HeLa cells were added in 6-well plates for cultivation. When cell confluence was 80%, scratches were produced in cell layer using sterile pipette tip. Afterward, cells were cleaned using PBS and incubated in a culture medium for 24 h. Images of migrating cells were detected at last.
Western blot
Total protein was reaped in Radio Immunoprecipitation Assay (RIPA) lysis buffer (Beyotime, Shanghai, China). Bicinchoninic acid (BCA) kit (Beyotime) determined protein concentrations. Proteins were separated through sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and moved onto polyvinylidene fluoride (PVDF) membranes. The membranes were sealed with 5% skimmed milk and cultivated with primary antibodies against UBE2Q1 (orb77618, Biorbyt, San Francisco, California, USA) and GAPDH (ab8245, Abcam, Cambridge, UK). Secondary antibody was added for incubating for 1 h. GAPDH was an internal control. Proteins quantities were evaluated via chemiluminescence detection system.
Luciferase reporter assay
The wild-type (WT) and mutant (Mut) binding sites of miR-1179 in circOSBPL10 or UBE2Q1 3′UTR was sub-cloned into pmirGLO dual-luciferase vector to construct circOSBPL10-WT/Mut or UBE2Q1-WT/Mut. And plasmids were co-transfected with miR-1179 mimics or NC mimics into SiHa and HeLa cells, respectively. The pGL3-OSBPL10 promoter was co-transfected with pcDNA3.1/FOXA1 or pcDNA3.1 into cells. Dual-Luciferase Reporter Assay System (Promega, USA) detected the luciferase activity.
Subcellular fractionation
Fractions of cytoplasmic and nuclear were separated using NE-PER™ Nuclear and Cytoplasmic Extraction Reagents (Invitrogen) and gathered by RNeasy Midi Kit (Qiagen, Hilden, Germany) to determine the cellular localization of circOSBPL10. RT-qPCR was used to examine the levels of circOSBPL10, U6 (nuclear control) and GAPDH (cytoplasmic control).
RNA pull-down
Briefly, cell lysates were incubated with biotinylated RNA including Bio-miR-1179-WT, Bio-miR-1179-Mut and Bio-NC. Moreover, M-280 streptavidin magnetic beads (Sigma-Aldrich) were added to co-culture for 48 h. The relative enrichment of RNAs pulled down in each group were assayed by RT-qPCR.
RNA immunoprecipitation (RIP)
RIP assays were progressed with Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Millipore, Bedford, USA). SiHa and HeLa cells were lysed with RIP lysis buffer, followed by incubation with magnetic beads conjugated with anti-Ago2 (Millipore) or anti-IgG (Millipore). The RT-qPCR was performed to evaluate the expression levels of circOSBPL10, miR-1179 and UBE2Q1 in the precipitates.
Chromatin immunoprecipitation (ChIP)
Via Magna ChIP Kit (Millipore), ChIP experiment was achieved. DNA in cell lysates was interrupted into 200-300-bp chromatin fragments by ultrasound. After that, lysates were subjected to immunoprecipitation with anti-FOXA1 or anti-IgG (negative control group). The precipitated DNA fragments were detected by RT-qPCR.
Statistical analysis
Experimental data from at least three independent experiments were shown as mean ± standard deviation (SD). Statistical analysis was performed using GraphPad Prism 7.0 software (Graph Pad, La Jolla, CA, USA). Significance in differences between 2 or more groups was analyzed via student’s t test or one-way analysis of variance (ANOVA). P < 0.05 had statistical significance in requirements.
Discussion
Mounting evidence has manifested that circRNAs serve vital parts in CC initiation and progression. For instance, circRNA SMARCA5 regulates CC progression by sponging miR-620 [
26]. Increased expression of circ_0067934 accelerates CC development by targeting miR-545/EIF3C axis [
27]. CircRNA hsa_circ_0023404 plays an oncogenic part in CC [
28]. CircOSBPL10, derived from back-splicing of OSBPL10 mRNA, is a circular RNA that has not been studied in CC but is worth exploring. In this research, circOSBPL10 was evidenced to have a circular structure and possess high levels in CC. Additionally, silenced circOSBPL10 exerted suppressive impacts on CC cell proliferation and migration.
Increasing researches have elucidated that circRNAs might serve as a molecular sponge of specific miRNAs, which has been suggested to be of significant value in CC [
29,
30], so as to regulate the tumorigenesis and development of numerous cancers including CC [
22,
23]. In current study, on the basis of bioinformatics prediction and molecular mechanism experiments, miR-1179 that was unveiled as an anti-tumor regulator in some cancers [
31,
32], was screened out and validated to be implicated in circOSBPL10- regulated cellular processes in CC.
Previously, UBE2Q1 has been depicted as a critical participator in tumor progression [
33,
34]. In present study, UBE2Q1 was verified capable of binding with miR-1179, and its expression was boosted by circOSBPL10 in CC through miR-1179 sequestration. More importantly, the follow-up rescue experiments indicated that UBE2Q1 upregulation or miR-1179 inhibition could rescue circOSBPL10 depletion-mediated suppressive effects on malignant phenotypes in CC.
Increasing researches have indicated that FOXA1 expresses at high levels in many cancers, such as lung cancer [
35], glioma [
36] and prostate cancer [
37]. Besides, a previous study indicated that FOXA1 could directly bind with PLOD2 promoter and activate PLOD2 transcription in NSCLC [
38]. Similarly, we revealed that FOXA1 activates OSBPL10 transcription and thereby facilitates circOSBPL10 expression in CC in this study.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.